Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000607388 | SCV000732439 | benign | not specified | 2017-12-21 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001083908 | SCV000756574 | benign | Reticular dysgenesis | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000635196 | SCV001147221 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | AK2: BP4, BS2 |
Baylor Genetics | RCV001083908 | SCV001529095 | uncertain significance | Reticular dysgenesis | 2018-05-09 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Prevention |
RCV003917972 | SCV004736589 | benign | AK2-related disorder | 2019-05-06 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |